{"organizations": [], "uuid": "6fd4625286e3895df08333944ba60c56e4668c17", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180309.html", "section_title": "Archive News &amp; Video for Friday, 09 Mar 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-oncology-venture-and-medical-progn/brief-oncology-venture-and-medical-prognosis-institute-agree-on-joint-merger-plan-idUSFWN1QR066", "country": "US", "domain_rank": 408, "title": "BRIEF-Oncology Venture And Medical Prognosis Institute Agree On Joint Merger Plan", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-09T15:09:00.000+02:00", "replies_count": 0, "uuid": "6fd4625286e3895df08333944ba60c56e4668c17"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-oncology-venture-and-medical-progn/brief-oncology-venture-and-medical-prognosis-institute-agree-on-joint-merger-plan-idUSFWN1QR066", "ord_in_thread": 0, "title": "BRIEF-Oncology Venture And Medical Prognosis Institute Agree On Joint Merger Plan", "locations": [], "entities": {"persons": [], "locations": [{"name": "sweden", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}, {"name": "gdynia newsroom", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 9 (Reuters) - ONCOLOGY VENTURE SWEDEN AB:\n* PROPOSED MERGER BETWEEN ONCOLOGY VENTURE AND MEDICAL PROGNOSIS INSTITUTE\n* MERGER WILL BE IMPLEMENTED WITH MPI AS CONTINUING LEGAL ENTITY AND OV AS DISCONTINUING ENTITY​\n* ‍FOLLOWING COMPLETION OF MERGER COMBINED COMPANY WILL BE REFERRED TO AS ‘ONCOLOGY VENTURE’​\n* ‍EXPECTED OPERATIONAL SYNERGIES AMOUNT TO MORE THAN SEK 2 MILLION PER YEAR.​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-03-09T15:09:00.000+02:00", "crawled": "2018-03-10T20:01:44.008+02:00", "highlightTitle": ""}